200,000+ products from a single source!

sales@angenechem.com

Home > Other Building Blocks > 84-60-6

84-60-6

84-60-6 | 2,6-Dihydroxyanthracene-9,10-dione

CAS No: 84-60-6 Catalog No: AG00331R MDL No:MFCD00001228

Product Description

Catalog Number:
AG00331R
Chemical Name:
2,6-Dihydroxyanthracene-9,10-dione
CAS Number:
84-60-6
Molecular Formula:
C14H8O4
Molecular Weight:
240.2109
MDL Number:
MFCD00001228
IUPAC Name:
2,6-dihydroxyanthracene-9,10-dione
InChI:
InChI=1S/C14H8O4/c15-7-1-3-9-11(5-7)14(18)10-4-2-8(16)6-12(10)13(9)17/h1-6,15-16H
InChI Key:
APAJFZPFBHMFQR-UHFFFAOYSA-N
SMILES:
Oc1ccc2c(c1)C(=O)c1c(C2=O)cc(cc1)O
EC Number:
201-544-3
UNII:
W83883330W
NSC Number:
33531

Properties

Complexity:
342  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
240.042g/mol
Formal Charge:
0
Heavy Atom Count:
18  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
240.214g/mol
Monoisotopic Mass:
240.042g/mol
Rotatable Bond Count:
0
Topological Polar Surface Area:
74.6A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
2.2  

Literature

Title Journal
Determination of the optical GAP in thin films of amorphous dilithium phthalocyanine using the Tauc and Cody models. Molecules (Basel, Switzerland) 20120824
Phenol transformation photosensitised by quinoid compounds. Physical chemistry chemical physics : PCCP 20110621
Correlation between bilirubin glucuronidation and estradiol-3-gluronidation in the presence of model UDP-glucuronosyltransferase 1A1 substrates/inhibitors. Drug metabolism and disposition: the biological fate of chemicals 20110201
Electrical and optical properties of copper and nickel molecular materials with tetrabenzo [b,f,j,n] [1,5,9,13] tetraazacyclohexadecine thin films grown by the vacuum thermal evaporation technique. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20100101
Structure-activity relationships of anthraquinones on the suppression of DNA-binding activity of the aryl hydrocarbon receptor induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Journal of bioscience and bioengineering 20090301
Correlation between reduction potentials and inhibitions of Epstein-Barr virus activation by anthraquinone derivatives. Bioorganic & medicinal chemistry letters 20080715
Synthesis and anti-inflammatory activity of 3-(4'-geranyloxy-3'-methoxyphenyl)-2-trans propenoic acid and its ester derivatives. Bioorganic & medicinal chemistry letters 20071015
Interaction of anthracene and its oxidative derivatives with human serum albumin. Acta biochimica Polonica 20060101
Structure and kinetics of a transient antibody binding intermediate reveal a kinetic discrimination mechanism in antigen recognition. Proceedings of the National Academy of Sciences of the United States of America 20050906
Differential and special properties of the major human UGT1-encoded gastrointestinal UDP-glucuronosyltransferases enhance potential to control chemical uptake. The Journal of biological chemistry 20040109
The specificity of cross-reactivity: promiscuous antibody binding involves specific hydrogen bonds rather than nonspecific hydrophobic stickiness. Protein science : a publication of the Protein Society 20031001
The effect of incubation conditions on the enzyme kinetics of udp-glucuronosyltransferases. Drug metabolism and disposition: the biological fate of chemicals 20030601
Evidence for phosphorylation requirement for human bilirubin UDP-glucuronosyltransferase (UGT1A1) activity. Biochemical and biophysical research communications 20030328
Inhibition and active sites of UDP-glucuronosyltransferases 2B7 and 1A1. Drug metabolism and disposition: the biological fate of chemicals 20021201
Differential modulation of UDP-glucuronosyltransferase 1A1 (UGT1A1)-catalyzed estradiol-3-glucuronidation by the addition of UGT1A1 substrates and other compounds to human liver microsomes. Drug metabolism and disposition: the biological fate of chemicals 20021101
Biosynthesis of drug glucuronides for use as authentic standards. Journal of pharmacological and toxicological methods 20020101
Induction of cytochromes P450 1A1 and 1B1 by emodin in human lung adenocarcinoma cell line CL5. Drug metabolism and disposition: the biological fate of chemicals 20010901
Phytoestrogens from the roots of Polygonum cuspidatum (Polygonaceae): structure-requirement of hydroxyanthraquinones for estrogenic activity. Bioorganic & medicinal chemistry letters 20010723
Hydroxyquinones are competitive non-peptide inhibitors of HIV-1 proteinase. Biochimica et biophysica acta 19951115
Stable expression of a human liver UDP-glucuronosyltransferase (UGT2B15) with activity toward steroid and xenobiotic substrates. Drug metabolism and disposition: the biological fate of chemicals 19940101
Evaluation of the antiviral activity of anthraquinones, anthrones and anthraquinone derivatives against human cytomegalovirus. Antiviral research 19920101

© 2019 Angene International Limited. All rights Reserved.